Basic Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jan 21, 2025; 31(3): 95207
Published online Jan 21, 2025. doi: 10.3748/wjg.v31.i3.95207
Figure 3
Figure 3 Identification of mRNA candidates. A: Diagram representing the study design; B: Bubble plots of enriched GSEA terms in HepG2 cells; C: SNU449 cells treated with Sorafenib 24 hours. Bubble size is representative of gene count and color is representative of the normalized enrichment score; D: Heatmap of selected mRNAs in HepG2 and SNU449 cells.